Immuneering (IMRX) Current Leases (2020 - 2026)
Immuneering (IMRX) posted quarterly Current Leases of $412835.0 for Q1 2026, up 17.11% year-over-year from $352521.0 in Q1 2025, and up 3.96% quarter-over-quarter from $397104.0 in Q4 2025.
Powered by 
Analysis
Immuneering (IMRX) Current Leases (2020 - 2026) Analysis & Trends
Immuneering's Current Leases history runs 7 years deep, the most recent figure standing at $412835.0 for Q1 2026.
- In Q1 2026, Current Leases rose 17.11% year-over-year to $412835.0; the TTM figure through Mar 2026 stood at $412835.0 (up 17.11% YoY), while the FY2025 annual figure was $397104.0, up 17.33% from the prior year.
- Current Leases for Q1 2026 stood at $412835.0, up from $397104.0 in the prior quarter.
- The five-year high for Current Leases was $412835.0 in Q1 2026, with the low at $265419.0 in Q1 2022.
- The 5-year median for Current Leases is $332675.0 (2023), against an average of $336540.2.
- The sharpest annual moves came in 2022 and 2023: Current Leases surged 272.84% in 2022, then dropped 20.76% in 2023.
- Immuneering's Current Leases stood at $378723.0 in 2022, then decreased by 20.76% to $300107.0 in 2023, then gained by 12.77% to $338438.0 in 2024, then gained by 17.33% to $397104.0 in 2025, then advanced by 3.96% to $412835.0 in 2026.
- Business Quant data shows IMRX's Current Leases at $412835.0 in Q1 2026, $397104.0 in Q4 2025, and $381760.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Immuneering | 316.69 Mn | 316.69 Mn | - | 428,962.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 428,962.00 |
| Mar 31, 2026 | 412,835.00 |
| Dec 31, 2025 | 397,104.00 |
| Sep 30, 2025 | 381,760.00 |
| Jun 30, 2025 | 366,959.00 |
| Mar 31, 2025 | 352,521.00 |
| Dec 31, 2024 | 338,438.00 |
| Sep 30, 2024 | 324,702.00 |
| Jun 30, 2024 | 311,459.00 |
| Mar 31, 2024 | 298,543.00 |
| Dec 31, 2023 | 300,107.00 |
| Sep 30, 2023 | 301,633.00 |
| Jun 30, 2023 | 332,675.00 |
| Mar 31, 2023 | 363,238.00 |
| Dec 31, 2022 | 378,723.00 |
| Sep 30, 2022 | 308,694.00 |
| Jun 30, 2022 | 286,374.00 |
| Mar 31, 2022 | 265,419.00 |
| Dec 31, 2021 | 274,039.00 |
| Sep 30, 2021 | 82,795.00 |